News for 'Export Administration Regulations'

India-US Trade Rift Deepens Over Section 301 Hearings

India-US Trade Rift Deepens Over Section 301 Hearings

Rediff.com22 May 2026

American industry groups sought punitive tariffs on Indian goods at USTR hearings, while Indian officials defended the country's manufacturing growth as demand-led and WTO-compliant.

Why Smallcaps Are Winning The Market Battle

Why Smallcaps Are Winning The Market Battle

Rediff.com26 Jun 2026

The remarkable rise of smallcaps reflects the emergence of a broad set of specialised businesses operating in industries where the sectoral tailwinds remain considerably stronger than macroeconomic headwinds, points out Debashis Basu.

Time India Embraces China And US

Time India Embraces China And US

Rediff.com26 Jun 2026

India's dual pursuit of a robust strategic partnership with Washington and a pragmatic, tension-management policy with Beijing represents the essence of modern multi-alignment. By embracing economic pragmatism, learning to compartmentalize political differences, and engaging in continuous dialogue, India can secure its borders, grow its economy, and contribute to a stable, multipolar Asian century, points out Ambassador Rajasekhar.

US raises concerns over India's data protection, internet shutdown policies

US raises concerns over India's data protection, internet shutdown policies

Rediff.com10 Apr 2026

The United States Trade Representative (USTR) has expressed concerns that India's Digital Personal Data Protection (DPDP) Act, particularly the lack of a deemed consent mechanism for credit information companies, and the Information Technology (IT) Rules of 2021, along with frequent internet shutdowns, could negatively impact the ability of US companies to operate and trade in India.

Vijay Must Demonstrate His Government Doesn't Engage In Theft

Vijay Must Demonstrate His Government Doesn't Engage In Theft

Rediff.com27 May 2026

If TVK MLAs and ministers are perceived as clean, or demonstrably cleaner than their predecessors, the credibility dividend will be enormous. The voter will feel rewarded, points out Ramesh Menon.

Iran: Why Trump Must Take A Leap Of Faith

Iran: Why Trump Must Take A Leap Of Faith

Rediff.com23 Apr 2026

There are enough people at the top decision-making level in Tehran who are still willing to negotiate, provided Trump can create the right setting for the negotiation to acquire a dynamic of its own, points out Ambassador M K Bhadrakumar.

Bhutan's Huge Crypto Gamble, India And China Watching

Bhutan's Huge Crypto Gamble, India And China Watching

Rediff.com16 Apr 2026

Is Bhutan merely experimenting with digital finance -- or is the Himalayan kingdom punching far above its weight, quietly playing one of the most sophisticated strategic games in Asia today? asks Varun Arya.

Will Budget 2026 Fix The Customs-FTA Disconnect?

Will Budget 2026 Fix The Customs-FTA Disconnect?

Rediff.com31 Jan 2026

Customs regimes can lead to labyrinthine legal disputes. Budget 2026 must recognise that an excessively defensive Customs posture can itself become a trade barrier, point out Mukesh Butani and Shankey Agrawal.

USTR flags hurdles in medical device exports to India

USTR flags hurdles in medical device exports to India

Rediff.com2 Apr 2025

The USTR report, released just ahead of the US' April 2 deadline for implementing reciprocal tariffs, has also cited high tariffs and price caps, which have not increased in line with inflation, as key obstacles for US businesses.

Has US Repeated Its Iraq Mistake?

Has US Repeated Its Iraq Mistake?

Rediff.com11 Mar 2026

Israel and the United States had a plan. Iran punched back. And now the Gulf is reeling, the world is beginning to feel the pain and, as on date, no one in Washington or Tel Aviv appears willing to admit that the punch has landed, notes Prem Panicker, continuing his must-read blog on the war in the Middle East.

Pune Firm Unveils Diabetes-Control Implant

Pune Firm Unveils Diabetes-Control Implant

Rediff.com19 Nov 2025

This innovation works by stimulating our natural organs so that it can produce and maintain the insulin balance.

Why US-China Face-Off Is Advantage India

Why US-China Face-Off Is Advantage India

Rediff.com29 Oct 2025

Amid US-China trade tensions and economic vulnerabilities, India must seize the 'China +1' opportunity, deepen reforms, secure FTAs, and globalise its firms for long-term growth, suggests Ajay Shah.

Under the lens: Regulator moots pre-export govt testing for cough syrup cos

Under the lens: Regulator moots pre-export govt testing for cough syrup cos

Rediff.com24 May 2023

After reports of contamination in cough syrups sent from the country, India is considering a system to test them before exporting. It is learnt that the Central Drugs Standard Control Organisation (CDSCO) has sent a proposal to the Union health ministry on this. The idea is to test the medicines at government labs before exporting.

India's EU Trade Deal Has A LONG Way To Go

India's EU Trade Deal Has A LONG Way To Go

Rediff.com18 Sep 2025

'Even if tariffs are reduced, non-tariff may still remain a challenge.'

US removes restrictions on 3 Indian nuclear entities

US removes restrictions on 3 Indian nuclear entities

Rediff.com16 Jan 2025

In a significant move, the United States on Wednesday removed restrictions on three Indian nuclear entities, over a week after National Security Advisor Jake Sullivan announced that Washington was finalising steps to 'remove' hurdles for civil nuclear partnership between Indian and American firms.

Cough syrup deaths: No state follows pharma safety norms

Cough syrup deaths: No state follows pharma safety norms

Rediff.com10 Oct 2025

The Central Drugs Standard Control Organisation (CDSCO) will conduct testing, inspection and auditing of cough syrup manufacturers.

How India's pharma cos plan to tackle steep US tariffs

How India's pharma cos plan to tackle steep US tariffs

Rediff.com10 Sep 2025

As the potential threat of a steep 200 per cent tariff on pharmaceutical imports hangs in the air, analysts and industry insiders feel that focus on exports to non-US regions as well as domestic market will increase as a long-term trend. US President Donald Trump told CNBC's Squawk Box in the first week of August that planned tariffs on import of pharmaceutical products to the US could eventually reach up to 250 per cent.

India draws up blueprint to reduce US trade surplus

India draws up blueprint to reduce US trade surplus

Rediff.com28 Apr 2025

India's major imports from the US include crude oil and petroleum products, gold and jewellery, plastics, aircraft, and electrical machinery and components. The key exports to the US comprise pharmaceuticals and biologicals, telecom equipment, precious and semi-precious stones, petroleum products, gold and precious metal jewellery, and ready-made garments.

SC forms SIT to probe complaints against Vantara

SC forms SIT to probe complaints against Vantara

Rediff.com26 Aug 2025

The Supreme Court of India has formed a Special Investigation Team (SIT) to investigate allegations of non-compliance with laws and irregularities at Vantara, a Green Zoological Rescue and Rehabilitation Centre in Gujarat. The SIT will examine the acquisition of animals, compliance with wildlife protection laws, and other related issues.

Explained: Trump's H1 Order Decoded

Explained: Trump's H1 Order Decoded

Rediff.com14 Oct 2025

A deep dive into Trump's new policy and what it means for Indian professionals and companies.

Trump offers olive branch to China after counter tariffs

Trump offers olive branch to China after counter tariffs

Rediff.com5 Apr 2025

US President Donald Trump has proposed a deal to China that would see the sale of TikTok's US operations to an American buyer in exchange for a reduction in tariffs on Chinese exports to the US. The proposal comes amid a trade war between the two countries and follows China's retaliation of Trump's tariffs on Chinese goods. Trump has also said that tariffs are a powerful economic tool and that he is determined to ensure fair trade between the US and China.

'India Can Convert Tariffs Into Win-Win Situation'

'India Can Convert Tariffs Into Win-Win Situation'

Rediff.com11 Aug 2025

'It's important for India to think about areas where it wants the US to move.' 'We can be far more innovative in what we ask the US.' 'Given that there's a package deal, why not do it?'

India eyes trade pact push as US pauses reciprocal tariffs for 3 months

India eyes trade pact push as US pauses reciprocal tariffs for 3 months

Rediff.com11 Apr 2025

With US President Donald Trump "temporarily suspending" country-specific reciprocal tariffs until July 9, India sees the three-month window as an opportunity to renew its push for a proposed bilateral trade agreement (BTA) with the US and expedite finalisation of the first tranche of the trade deal.

India better placed than China in trade with US: Experts

India better placed than China in trade with US: Experts

Rediff.com6 Nov 2024

Donald Trump's Presidency of the United States will open new opportunities for India though certain sectors, especially pharma and IT, may face the heat if the incoming president decides to impose restrictions on imports and H1B visa regulations, experts said on Wednesday. Prime Minister Narendra Modi's friendly relationship with Trump will have a positive bearing on Indo-US relations but India may have to adapt its strategies to maintain cooperation in areas of mutual interest.

India hopes for temporary tariff waiver as US official comes calling

India hopes for temporary tariff waiver as US official comes calling

Rediff.com24 Mar 2025

India and the United States will finalize the contours, schedule of negotiations, and terms of reference for a proposed bilateral trade agreement (BTA) during a three-day meeting beginning Tuesday. The agreement is expected to be finalized in two tranches, with the first phase focusing on goods trade. The US team, led by Assistant US Trade Representative for South and Central Asia Brendan Lynch, will be in India from March 25-29 to discuss the agreement. Both countries are aiming to conclude the first phase of the agreement by fall 2025.

'Trump Has Been Threatening India'

'Trump Has Been Threatening India'

Rediff.com25 Mar 2025

'Many of these issues will be resolved within 6 months because the US economy has started unravelling.'

Trump 2.0: Govt In Wait-And-Watch Mood

Trump 2.0: Govt In Wait-And-Watch Mood

Rediff.com8 Nov 2024

'We may see even more restrictive policies during 2.0.'

Trump Has Become A Reset Button

Trump Has Become A Reset Button

Rediff.com11 Apr 2025

Trump's sweeping tariffs and penalties on China-built ships have turned global shipping into the front line of economic war, observes Shyam G Menon.

USTR Report Intensifies Trade Tensions With India

USTR Report Intensifies Trade Tensions With India

Rediff.com2 Apr 2025

The US Trade Representative noted that India's average applied tariff rate stood at 17% per cent, the highest of any major world economy.

Trump 2.0: Tough Navigation Lies Ahead For India

Trump 2.0: Tough Navigation Lies Ahead For India

Rediff.com12 Feb 2025

'As the global economy undergoes significant transformations in 2025, India's ability to navigate the complexities of trade wars, financial realignments, and emerging blocs will be pivotal,' explain Harsh V Pant and Soumya Bhowmik.

Should World Be Afraid Of China's DeepSeek?

Should World Be Afraid Of China's DeepSeek?

Rediff.com28 Jan 2025

Cheaper ripoffs was how China powered its way as an economic superpower but hitherto the tech realm had remained out of bounds. With DeepSeek's AI model the West, it seemed, was about to lose its competitive edge in cutting edge generative AI technology. And this is what is causing deep furrows in the forehead of tech titans in Silicon Valley.

'Musk, Vivek biggest threat for China'

'Musk, Vivek biggest threat for China'

Rediff.com24 Nov 2024

United States President-elect Donald Trump's plan to overhaul the government with a new department headed by tech billionaire Elon Musk and Indian-origin entrepreneur Vivek Ramaswamy will be a biggest threat for China as it has to compete with far more efficient US political system, a policy advisor to the Chinese government said.

As domestic sales decline, drug makers focus on exports

As domestic sales decline, drug makers focus on exports

Rediff.com1 Oct 2020

While sales in the domestic market declined 4.2 per cent during the April-July period, exports grew steadily at 9.5 per cent during the same period.

India AI mission to be key priority for telecom ministry

India AI mission to be key priority for telecom ministry

Rediff.com18 Jun 2024

Many who track the ministry and the technology sector closely believe that the space won't see much impact on the policymaking side, but the gestation time for regulations might get long, as now there could be a wider consensus-building exercise on policy matters under a coalition government.

UK food regulator gives clean chit to Maggi

UK food regulator gives clean chit to Maggi

Rediff.com1 Jul 2015

Nestle India currently exports Maggi noodles to Canada, UK, Singapore and Kenya and to third parties in the US, Australia and New Zealand

Local drug makers worried as regulators start working together

Local drug makers worried as regulators start working together

Rediff.com26 Dec 2013

Various domestic companies such as Ranbaxy, Wockhardt and Agila Specialities recently came under the US FDA scanner for lapse in manufacturing practices.

FSSAI launches probe into MDH and Everest products

FSSAI launches probe into MDH and Everest products

Rediff.com23 Apr 2024

The Food Safety and Standards Authority of India (FSSAI) has commissioned a quality check on MDH and Everest products. This follows complaints that several popular spice mixes of the two leading brands contained traces of ethylene oxide more than the permissible levels, official sources said. This move by FSSAI comes after Hong Kong and Singapore recalled variants of the two masala majors' products in their countries.

US paves way for high-tech product sales to India

US paves way for high-tech product sales to India

Rediff.com4 Aug 2018

India has become the 37th country to join the list of Strategic Trade Authorization-1 category, the only South Asian nation.

Drug regulator to make routine inspection of Chinese suppliers

Drug regulator to make routine inspection of Chinese suppliers

Rediff.com15 Nov 2013

Move follows a spate of international regulatory enforcements on Indian drug firms.